Categories
Uncategorized

Bictegravir

Bictegravir is a second-generation integrase inhibitor (INSTI) class that was structurally derived from an earlier compound dolutegravir.

The combination drug bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy) is approved for use in HIV in the United States

Leave a Reply

Your email address will not be published. Required fields are marked *